Atrás
Rango del Día
$8.84
$9.18
Rango de 52 Semanas
$8.72
$15.55
Volumen
706,301
Promedio 50D / 200D
$10.51
/
$12.02
Cierre Anterior
$9.01
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 5.6 | 0.2 |
| P/B | — | 3.0 |
| ROE % | — | 3.6 |
| Net Margin % | 8.8 | 3.8 |
| Rev Growth 5Y % | -1.9 | 9.9 |
| D/E | — | 0.2 |
Precio Objetivo de Analistas
Hold
$22.50
+150.0%
Low: $20.00
High: $25.00
P/E Futuro
3.20
EPS Futuro
$2.82
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
1.07B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$3.06
$3.05 – $3.07
|
940.52M | 1 |
| FY2029 |
$2.96
$2.95 – $2.97
|
966.97M | 1 |
| FY2028 |
$2.98
$2.35 – $3.48
|
1.08B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-05 | $0.67 | $0.71 | +5.8% |
| 2025-11-25 | $0.70 | $0.50 | -28.6% |
| 2025-08-08 | $0.46 | $1.12 | +146.2% |
| 2025-05-09 | $0.66 | $0.70 | +6.1% |
| 2025-02-06 | $0.45 | $0.65 | +44.4% |
| 2024-11-26 | $0.36 | $0.45 | +25.0% |
| 2024-08-09 | $0.48 | $0.74 | +54.2% |
| 2024-05-09 | $0.43 | $0.67 | +55.8% |
Dividend History
4 yr streakYield
0.04%
Payout Ratio
0.37%
Growth (3Y)
25.99%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 27, 2026 | Mar 17, 2026 | $0.15 | 5.85% |
| Dec 05, 2025 | Dec 18, 2025 | $0.15 | 5.13% |
| Aug 29, 2025 | Sep 15, 2025 | $0.15 | 4.14% |
| May 28, 2025 | Jun 13, 2025 | $0.15 | 5.69% |
| Feb 28, 2025 | Mar 14, 2025 | $0.15 | 4.44% |
| Dec 06, 2024 | Dec 18, 2024 | $0.15 | 3.12% |
| Aug 27, 2024 | Sep 13, 2024 | $0.15 | 4.11% |
| May 24, 2024 | Jun 14, 2024 | $0.15 | 4.57% |
| Feb 27, 2024 | Mar 15, 2024 | $0.15 | 4.16% |
| Dec 01, 2023 | Dec 15, 2023 | $0.15 | 3.26% |
| Aug 24, 2023 | Sep 13, 2023 | $0.15 | 3.54% |
| May 25, 2023 | Jun 13, 2023 | $0.15 | 2.20% |
| Feb 24, 2023 | Mar 13, 2023 | $0.15 | 1.44% |
| Dec 29, 2022 | Jan 11, 2023 | $0.15 | 1.16% |
| Aug 25, 2022 | Sep 14, 2022 | $0.15 | 0.45% |
Puntos Clave
Revenue declined -1.87% annually over 5 years
Earnings grew 21.84% over the past year
Generating 182.40M in free cash flow
P/E of 5.59 — trading at a low valuation
PEG of 0.42 suggests growth is underpriced
Cash machine — converts 191.19% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
-1.87%
Revenue (1Y)-3.80%
Earnings (1Y)21.84%
FCF Growth (3Y)110.41%
Calidad
Return on Equity
N/A
ROIC31.68%
Net Margin8.83%
Op. Margin30.48%
Seguridad
Debt / Equity
N/A
Current Ratio2.41
Interest Coverage3.07
Valoración
P/E Ratio
5.59
Forward P/E3.20
P/B RatioN/A
EV/EBITDA5.28
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.80% | Revenue Growth (3Y) | -1.82% |
| Earnings Growth (1Y) | 21.84% | Earnings Growth (3Y) | 16.41% |
| Revenue Growth (5Y) | -1.87% | Earnings Growth (5Y) | -30.75% |
| Profitability | |||
| Revenue (TTM) | 1.08B | Net Income (TTM) | 95.40M |
| ROE | N/A | ROA | 8.75% |
| Gross Margin | 62.89% | Operating Margin | 30.48% |
| Net Margin | 8.83% | Free Cash Flow (TTM) | 182.40M |
| ROIC | 31.68% | FCF Growth (3Y) | 110.41% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.41 |
| Interest Coverage | 3.07 | ||
| Dividends | |||
| Dividend Yield | 0.04% | Payout Ratio | 0.37% |
| Dividend Growth (3Y) | 25.99% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 4 yrs | ||
| Valuation | |||
| P/E Ratio | 5.59 | Forward P/E | 3.20 |
| P/B Ratio | N/A | P/S Ratio | 0.49 |
| PEG Ratio | 0.42 | Forward PEG | N/A |
| EV/EBITDA | 5.28 | Fwd EV/EBITDA | 5.70 |
| Forward P/S | 0.50 | Fwd Earnings Yield | 31.25% |
| FCF Yield | 34.22% | ||
| Market Cap | 532.98M | Enterprise Value | 1.74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.08B | 1.12B | 1.12B | 1.13B | 1.17B |
| Net Income | 95.40M | 78.30M | 70.40M | 223.60M | 414.80M |
| EPS (Diluted) | 1.62 | 1.34 | 1.22 | 3.89 | 7.31 |
| Gross Profit | 679.50M | 728.90M | 749.90M | 774.90M | 800.00M |
| Operating Income | 329.30M | 174.20M | 229.60M | 378.10M | 492.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.09B | 1.29B | 1.21B | 1.09B | 788.00M |
| Total Liabilities | 1.74B | 2.02B | 2.04B | 1.98B | 194.00M |
| Shareholders' Equity | -650.60M | -738.30M | -821.70M | -891.40M | 594.00M |
| Total Debt | 1.43B | 1.61B | 1.64B | 1.64B | 0.0 |
| Cash & Equivalents | 225.50M | 267.50M | 326.30M | 330.90M | 0.0 |
| Current Assets | 631.40M | 761.00M | 749.10M | 664.70M | 292.00M |
| Current Liabilities | 261.50M | 374.00M | 353.50M | 301.00M | 164.00M |